Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
BMJ Open
|
July 3, 2023
The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
Jack Gunn, Daniel O'Keefe, Bridget Louise Draper, et al.
Public Health Research & Practice
|
December 18, 2025
Viral hepatitis notifications: a cohort study of enhanced local follow-up in Victoria
Tiffany Pe, Phongsakone Inthavong, Emma Beavon, et al.
Open Forum Infectious Diseases
|
August 11, 2022
Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study
Timothy Papaluca, Anne Craigie, Lucy McDonald, et al.
BMC Public Health
|
October 16, 2021
Assessing the feasibility, acceptability and impacts of an education program on hepatitis B testing uptake among ethnic Chinese in Australia: results of a randomised controlled pilot study
Yinzong Xiao, Jack Wallace, Marvad Ahad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study
Marianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
BMJ Open
|
March 26, 2022
Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol
Tafireyi Marukutira, Karen P Moore, Margaret Hellard, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
BMJ Open
|
July 3, 2023
The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
Jack Gunn, Daniel O'Keefe, Bridget Louise Draper, et al.
Public Health Research & Practice
|
December 18, 2025
Viral hepatitis notifications: a cohort study of enhanced local follow-up in Victoria
Tiffany Pe, Phongsakone Inthavong, Emma Beavon, et al.
Open Forum Infectious Diseases
|
August 11, 2022
Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study
Timothy Papaluca, Anne Craigie, Lucy McDonald, et al.
BMC Public Health
|
October 16, 2021
Assessing the feasibility, acceptability and impacts of an education program on hepatitis B testing uptake among ethnic Chinese in Australia: results of a randomised controlled pilot study
Yinzong Xiao, Jack Wallace, Marvad Ahad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study
Marianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
BMJ Open
|
March 26, 2022
Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol
Tafireyi Marukutira, Karen P Moore, Margaret Hellard, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease
|
July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients
Joe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Page
of 9